Year archive

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. — 2024 filings

All 32 regulatory filings released by Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315) in 2024, sourced directly from the official regulator.

32 Filings

2024 Period

2024 filings (32)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-04	English
VOLUNTARY ANNOUNCEMENT IDEAYA'S NOMINATION OF DEVELOPMENT CANDIDATE IDE034, A POTENTIAL FIRST-IN-CLASS B7H3/PTK7 TOPO-I-PAYLOAD BISPECIFIC ADC AND OPTION EXERCISE Capital/Financing Update	2024-11-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Regulatory Filings	2024-10-02	English
2024 Interim Report Interim / Quarterly Report H1 2024	2024-09-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-02	English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024 Interim / Quarterly Report H1 2024	2024-08-28	English
DATE OF BOARD MEETING Regulatory Filings	2024-08-16	English
ANNOUNCEMENT ON PRELIMINARY FINANCIAL DATA FOR THE SIX MONTHS ENDED JUNE 30, 2024 Earnings Release H1 2024	2024-08-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-06	English
VOLUNTARY ANNOUNCEMENT ENTERS INTO OPTION AND LICENSE AGREEMENT WITH IDEAYA FOR POTENTIAL FIRST-IN-CLASS B7H3/PTK7 TOPO-I-PAYLOAD BISPECIFIC ADC PROGRAM Regulatory Filings	2024-07-31	English
VOLUNTARY ANNOUNCEMENT ENTERS INTO MULTI-TARGET ANTIBODY AGREEMENT WITH SOTIO Capital/Financing Update	2024-07-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Regulatory Filings	2024-07-03	English
VOLUNTARY ANNOUNCEMENT Biocytogen Secures U.S. Patent for RenLite Common Light Chain Mouse Platform Regulatory Filings	2024-06-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Regulatory Filings	2024-06-06	English
POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING HELD ON MAY 28, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-05-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Regulatory Filings	2024-05-07	English
FORM OF PROXY FOR THE USE AT THE 2023 ANNUAL GENERAL MEETING AGM Information	2024-04-25	English
NOTICE OF THE 2023 ANNUAL GENERAL MEETING AGM Information	2024-04-25	English
(1)2023 ANNUAL REPORT... (2)WORK REPORT OF BOARD (3)WORK REPORT OF SUPERVISORY COMMITTEE (4)FINAL ACCOUNTS REPORT (5)PROPOSED RE-APPOINTMENT OF AUDITOR (6)PROPOSED REMUNERATION OF DIRECTORS (7)PROPOSE AGM Information	2024-04-25	English
2023 Annual Report Annual Report FY 2023	2024-04-25	English
VOLUNTARY ANNOUNCEMENT (1) UNUSUAL PRICE MOVEMENT; AND (2) SHARE PURCHASE BY TRUSTEE PURSUANT TO SHARE AWARD SCHEME Capital/Financing Update	2024-04-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Regulatory Filings	2024-04-03	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 Annual Report FY 2023	2024-03-27	English
DATE OF BOARD MEETING Report Publication Announcement	2024-03-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-03-06	English
ANNOUNCEMENT ON PRELIMINARY FINANCIAL DATA FOR THE YEAR ENDED DECEMBER 31, 2023 Earnings Release FY 2023	2024-02-23	English
VOLUNTARY ANNOUNCEMENT BIOCYTOGEN AND GILEAD ENTER INTO A MULTI-TARGET ANTIBODY COLLABORATION AGREEMENT Regulatory Filings	2024-02-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-05	English
VOLUNTARY ANNOUNCEMENT BIOCYTOGEN ENTERED INTO A BISPECIFIC ANTIBODY DRUG CONJUGATE AGREEMENT WITH RADIANCE BIOPHARMA Capital/Financing Update	2024-01-08	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2024-01-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-05	English